FI930608A0 - PHARMACEUTICAL FORMULATION OF 5- (2-CHLORO-1-HYDROXYETHYL) -4-METHYLTHIAZOLE - Google Patents

PHARMACEUTICAL FORMULATION OF 5- (2-CHLORO-1-HYDROXYETHYL) -4-METHYLTHIAZOLE

Info

Publication number
FI930608A0
FI930608A0 FI930608A FI930608A FI930608A0 FI 930608 A0 FI930608 A0 FI 930608A0 FI 930608 A FI930608 A FI 930608A FI 930608 A FI930608 A FI 930608A FI 930608 A0 FI930608 A0 FI 930608A0
Authority
FI
Finland
Prior art keywords
methylthiazole
hydroxyethyl
chloro
pharmaceutical formulation
solvate
Prior art date
Application number
FI930608A
Other languages
Finnish (fi)
Other versions
FI930608A (en
Inventor
Bernard Robin Boar
Alan John Cross
Alfred Richard Green
Curt-Eric Hagberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI930608A publication Critical patent/FI930608A/en
Publication of FI930608A0 publication Critical patent/FI930608A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Abstract

New pharmaceutical formulations comprising 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or optical isomers or a pharmaceutically acceptable salt or solvate thereof.
FI930608A 1990-08-15 1993-02-11 PHARMACEUTICAL FORMULATION OF 5- (2-CHLORO-1-HYDROXYETHYL) -4-METHYLTHIAZOLE FI930608A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9002659A SE9002659D0 (en) 1990-08-15 1990-08-15 NEW PHARMACEUTICAL FORMULATIONS
PCT/SE1991/000522 WO1992003134A1 (en) 1990-08-15 1991-08-07 New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (2)

Publication Number Publication Date
FI930608A FI930608A (en) 1993-02-11
FI930608A0 true FI930608A0 (en) 1993-02-11

Family

ID=20380161

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930608A FI930608A0 (en) 1990-08-15 1993-02-11 PHARMACEUTICAL FORMULATION OF 5- (2-CHLORO-1-HYDROXYETHYL) -4-METHYLTHIAZOLE

Country Status (26)

Country Link
US (1) US5385921A (en)
EP (1) EP0619734B1 (en)
JP (1) JP3094077B2 (en)
AT (1) ATE164066T1 (en)
AU (1) AU657490B2 (en)
BG (1) BG97446A (en)
CA (1) CA2088775A1 (en)
CZ (1) CZ279586B6 (en)
DE (1) DE69129126T2 (en)
DK (1) DK0619734T3 (en)
ES (1) ES2114891T3 (en)
FI (1) FI930608A0 (en)
HU (1) HUT65821A (en)
IE (1) IE912818A1 (en)
IL (1) IL99169A (en)
IS (1) IS3743A7 (en)
LT (1) LT3978B (en)
LV (1) LV10921B (en)
NO (1) NO303447B1 (en)
NZ (1) NZ239329A (en)
PT (1) PT98688B (en)
RO (1) RO112994B1 (en)
RU (1) RU2093155C1 (en)
SE (1) SE9002659D0 (en)
SK (1) SK8793A3 (en)
WO (1) WO1992003134A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901658D0 (en) * 1999-05-06 1999-05-06 Astra Ab New formulation
SE9904177D0 (en) * 1999-11-18 1999-11-18 Astra Ab Novel compounds
AU2002314744A1 (en) 2001-04-17 2002-10-28 Sepracor, Inc. Thiazole and other heterocyclic ligands and use thereof
CN103772313B (en) * 2014-01-02 2015-10-14 郑桂富 A kind of synthetic method of 4-methyl-5-(2-hydroxyethyl) thiazole
CN112262814A (en) * 2020-10-26 2021-01-26 宜宾学院 Chicken raising method by cinnamomum longepaniculatum leaf residue fermentation bed

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2825966A1 (en) * 1978-06-14 1980-01-03 Basf Ag ACID GALVANIC NICKEL BATH, WHICH CONTAINS SULFOBETAINE AS A GLOSSY AND LEVELING AGENT
GB8600783D0 (en) * 1986-01-14 1986-02-19 Merck Sharp & Dohme N-methyl-d-aspartate receptor antagonists

Also Published As

Publication number Publication date
DE69129126D1 (en) 1998-04-23
DE69129126T2 (en) 1998-07-23
ATE164066T1 (en) 1998-04-15
SE9002659D0 (en) 1990-08-15
IL99169A (en) 1995-10-31
ES2114891T3 (en) 1998-06-16
LV10921A (en) 1995-12-20
US5385921A (en) 1995-01-31
CA2088775A1 (en) 1992-02-16
PT98688B (en) 1999-01-29
FI930608A (en) 1993-02-11
NO303447B1 (en) 1998-07-13
CZ16693A3 (en) 1994-02-16
HUT65821A (en) 1994-07-28
SK8793A3 (en) 1993-07-07
LV10921B (en) 1996-08-20
CZ279586B6 (en) 1995-05-17
LT3978B (en) 1996-06-25
IS3743A7 (en) 1992-02-16
NZ239329A (en) 1994-11-25
EP0619734A1 (en) 1994-10-19
RU2093155C1 (en) 1997-10-20
JP3094077B2 (en) 2000-10-03
BG97446A (en) 1994-03-24
JPH06500097A (en) 1994-01-06
IL99169A0 (en) 1992-07-15
NO930452D0 (en) 1993-02-09
AU8409291A (en) 1992-03-17
WO1992003134A1 (en) 1992-03-05
NO930452L (en) 1993-02-09
DK0619734T3 (en) 1998-10-05
LTIP1714A (en) 1995-09-25
EP0619734B1 (en) 1998-03-18
PT98688A (en) 1992-07-31
IE912818A1 (en) 1992-02-26
AU657490B2 (en) 1995-03-16
RO112994B1 (en) 1998-03-30
HU9300388D0 (en) 1993-04-28

Similar Documents

Publication Publication Date Title
NO914667D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLED DERIVATIVES
NO156785B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOBUTAN DERIVATIVES.
NO910935D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE C-BONDED PYRAZOLE DERIVATIVES.
NO171853C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7BETA- (2- (TIAZOL-4-YL) -2-ALCOXYIMINOACETAMIDO) -3 - ((1-PYRAZOLIO) METHYL) -3-CEFEM-4-CARBOXYLATE COMPOUND
NO903941D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DIAZEPINON DERIVATIVES.
NO172575C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOCYCLYLKANE DERIVATIVES
GR920100570A (en) 3(2h)-pyridazinone derivatives and process for the preparation thereof.
FI930608A (en) PHARMACEUTICAL FORMULATION OF 5- (2-CHLORO-1-HYDROXYETHYL) -4-METHYLTHIAZOLE
NO902710D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE R (-) 3-KINUCLIDINOL DERIVATIVES.
NO167734C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SUBSTITUTED AMINE DERIVATIVES.
TR27833A (en) "Pour-on" formulation for the application of anthelmintics.
ZA911452B (en) New use of 5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene-bis(dimethylcarbanate)
RU93004984A (en) PHARMACEUTICAL COMPOSITION BASED ON 5 (2-CHLOR-1-HYDROXYETHYLCH) -4-METHYL-THIASOLE, APPLICATION 5- (2-CHLOR-1-HYDROXYETHYL) -4-METHYL-TIAZOLE FOR TREATMENT, SPECIFICATION: TYPE HYDROXYETHYL TYPE -1-hydroxyethyl) -4-methylthiazole
IT1095388B (en) PHARMACEUTICAL COMPOSITION FOR THE ADMINISTRATION OF PANCREATIN
NO912979L (en) PROCEDURE FOR THE PREPARATION OF 2- (9-FLUORENOYL) CARBAPENE DERIVATIVES.
IT9021021A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ADMINISTRATION OF HIRUDIN
NO178302C (en) Analogous Process for the Preparation of Therapeutically Active, Substituted 3-Thia- and 3-Oxa-alkyl Flavones, and Intermediates for the Process
DK22983A (en) PROCEDURE FOR THE PREPARATION OF PENICILLIN DERIVATIVES
NO173140C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIENO-TRIAZOLO-DIAZEPINE DERIVATIVES
NO167974C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINOPROPANOLE DERIVATIVES OF 3- (2-HYDROXYPHENYL) -1-PROPANONE COMPOUNDS.
NO171451C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHENETANOLAMINE DERIVATIVES
IT9048110A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE RECTAL ADMINISTRATION OF CALCITONIN
MX9203359A (en) NEW PHARMACEUTICAL COMPOSITIONS OF INSULIN.
IT1100372B (en) ASSOCIATION OF ANTIBIOTICS CHARACTERIZED BY DECREASED TOXICITY, AND RELATIVE PHARMACEUTICAL COMPOSITIONS

Legal Events

Date Code Title Description
HC Name/ company changed in application

Owner name: ASTRA AKTIEBOLAG